Testing the therapeutic ability of cannabis Result: cannabinoids in migraine treatment
A total of 92 participants were enrolled and randomised, with 71 participants treating at least one migraine attack. The majority of participants were female, with a mean age of 41. Analysis of data from 234 migraine attacks revealed that the THC/CBD combination was superior to the placebo in:
- achieving pain relief (67.2% vs. 46.6%),
- pain freedom (34.5% vs. 15.5%),
- MBS freedom (60.3% vs. 34.5%).
https://cannabizeu.com/exploring-the-efficacy-of-cannabis-for-acute-migraine/